These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2966982)

  • 1. Trimetrexate as a single agent in patients with advanced head and neck cancer.
    Robert F
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):22-6. PubMed ID: 2966982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetrexate: a phase 2 study in previously treated patients with metastatic breast cancer.
    Leiby JM
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):27-31. PubMed ID: 2966983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response to trimetrexate as sole therapy for nonsmall cell lung cancer.
    Maroun J
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):17-21. PubMed ID: 2835816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma.
    Licht JD; Gonin R; Antman KH
    Cancer Chemother Pharmacol; 1991; 28(3):223-5. PubMed ID: 1830249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.
    Ajani JA; Abbruzzese JL; Faintuch JS; Patt YZ; Boman BM; Jackson DE; Levin B; Krakoff IH
    Cancer Invest; 1990; 8(6):619-21. PubMed ID: 2149834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic malignant melanoma with trimetrexate: a phase II study.
    Odujinrin O; Goldberg D; Doroshow J; Leong L; Margolin K; Grove W; Carr B; Akman S
    Med Pediatr Oncol; 1990; 18(1):49-52. PubMed ID: 2136764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.
    Kris MG; D'Acquisto RW; Gralla RJ; Burke MT; Marks LD; Fanucchi MP; Heelan RT
    Am J Clin Oncol; 1989 Feb; 12(1):24-6. PubMed ID: 2536213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group study.
    Fleming TR; Brown TD; Ross SW; Macdonald JS
    Invest New Drugs; 1996; 13(4):363-5. PubMed ID: 8824358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections.
    Jolivet J; Landry L; Pinard MF; McCormack JJ; Tong WP; Eisenhauer E
    Cancer Chemother Pharmacol; 1987; 20(2):169-72. PubMed ID: 2959389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetrexate: a second generation folate antagonist in clinical trial.
    Lin JT; Bertino JR
    J Clin Oncol; 1987 Dec; 5(12):2032-40. PubMed ID: 2960788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetrexate in advanced carcinoma of the esophagus.
    Alberts AS; Falkson G; Badata M; Terblanche AP; Schmid EU
    Invest New Drugs; 1988 Dec; 6(4):319-21. PubMed ID: 2976410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.
    Blanke CD; Kasimis B; Schein P; Capizzi R; Kurman M
    J Clin Oncol; 1997 Mar; 15(3):915-20. PubMed ID: 9060528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.
    Grochow LB; Noe DA; Ettinger DS; Donehower RC
    Cancer Chemother Pharmacol; 1989; 24(5):314-20. PubMed ID: 2758561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule.
    Stewart JA; McCormack JJ; Tong W; Low JB; Roberts JD; Blow A; Whitfield LR; Haugh LD; Grove WR; Lopez AJ
    Cancer Res; 1988 Sep; 48(17):5029-35. PubMed ID: 2970294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.